Department of Obstetrics and Gynecology, Huashan Hospital North, Fudan University, Shanghai, China (mainland).
Department of Obstetrics and Gynecology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China (mainland).
Med Sci Monit. 2021 Mar 11;27:e931225. doi: 10.12659/MSM.931225.
This paper is retracted at the author's request. Reference: Qiu Xin, An Muer: Girinimbine Inhibits the Proliferation of Human Ovarian Cancer Cells In Vitro via the Phosphatidylinositol-3-Kinase (PI3K)/Akt and the Mammalian Target of Rapamycin (mTOR) and Wnt/ß-Catenin Signaling Pathways. Med Sci Monit 2018; 24: 5480-5487. 10.12659/MSM.910137.
本文应作者要求撤回。参考文献:邱欣,安默:吉立替尼通过磷脂酰肌醇 3-激酶(PI3K)/蛋白激酶 B(Akt)和雷帕霉素靶蛋白(mTOR)及 Wnt/β-连环蛋白信号通路抑制人卵巢癌细胞的体外增殖。医学科学监测 2018;24: 5480-5487. 10.12659/MSM.910137.